Objectives: The role of sdiA in the acquisition of low-level multidrug resistance (MDR) was analysed and compared with that of marA and soxS in two Escherichia coli clinical isolates and two in vitro-selected mutants.
Introduction
Infections caused by multidrug-resistant Gram-negative bacilli have become a growing problem. In particular, resistance to fluoroquinolones is frequently associated with multidrug resistance (MDR) phenotypes in Escherichia coli and Klebsiella pneumoniae strains that produce extended-spectrum b-lactamases (ESBLs). Taking into account that b-lactams and fluoroquinolones are the most widely used antibiotics worldwide in human medicine, it is easy to understand the difficulty in finding adequate therapeutic options for the treatment of infections caused by Gram-negative bacteria. 1 In this background, low-level MDR, which is defined as decreased multidrug susceptibility, can serve as an intermediate step for the development of increased resistance that is clinically relevant. 2, 3 These low-level broad resistances are usually chromosomally mediated. The marA gene is part of the best-characterized locus for multiple antibiotic resistance, the mar locus, which encodes the marRAB operon. MarA overexpression-mediated resistance is characterized by reduced uptake and increased efflux from the cell, leading to a low level of resistance to distinct classes of antimicrobial agents, defined as the multiple antibiotic resistance (Mar) phenotype. 2 Transcription of marRAB is induced by chemicals, such as salicylate (5 mM), through inactivation of MarR, the repressor of marRAB expression. 4 Some of the genes of the marRAB regulon are also members of the redox-responsive soxRS regulon, which also confers MDR when it is activated. MarA and SoxS are sufficiently similar to activate a common subset of promoters, and these up-regulate several cellular functions that play significant roles in overall antibiotic resistance. 5 These two stress response regulators can lead to low-level MDR phenotypes by increasing expression of the AcrAB-TolC efflux system and elevating the synthesis of micF RNA, which is an antisense transcript that destabilizes the ompF mRNA. 6 -8 The acrA and acrB genes of the above-mentioned efflux system are transcribed from one operon with the acrR gene, # The Author 2010. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org a repressor of the operon that controls its activation transcribed divergently from a point downstream of the acrAB operon. Deletion or inactivation of acrR results in enhanced expression of acrAB and increases fluoroquinolone resistance in E. coli strains. 9, 10 It was previously suggested that mutations in the acrR repressor gene are more likely to be involved in acrB derepression than mutations that lead to marA or soxS overexpression. 9 Recently, the presence of quorum-sensing systems has been associated with MDR in Bacteroides fragilis. 11 In addition, up-regulation of multidrug transporters by quorum-sensing system regulators, such as sdiA in E. coli, has been described. In fact, sdiA amplification results in overexpression of the acrABtolC system without decreasing OmpF. 12 -14 SdiA is homologous to the LuxR family of quorum-sensing transcription factors, and its amplification has a global impact on several functions in bacterial cells, including cell septation (ftsQAZ cell division genes). 12, 13 This suppressor of division inhibition (SdiA) regulates cell division in a cell density-dependent (or quorum-sensing) manner. In turn, AcrAB has been proposed to pump out quorumsensing signals that do not easily diffuse on their own. 12 AcrAB is the major multidrug efflux transporter in E. coli, and it allows passage of fluoroquinolones, among other antimicrobials. 12 Interestingly, a 4-quinolone (2-heptyl-3-hydroxy-4-quinolone) is produced by Pseudomonas aeruginosa and functions as a quorumsensing signal. 15 In addition, sublethal concentrations of several antibiotics, including fluoroquinolones, also induce the quorumsensing regulatory lux genes.
14 Nevertheless, the role of SdiA in MDR selected by distinct classes of antibiotics, such as b-lactams or fluoroquinolones, is still unknown. Therefore, the aim of the present study was to evaluate a possible role for sdiA in low-level MDR acquisition in multidrug-resistant mutants selected with two different antimicrobials: a fluoroquinolone (lomefloxacin) and a b-lactam (ceftazidime).
Materials and methods

Bacterial strains and drugs
Sodium salicylate, carbonyl cyanide m-chlorophenylhydrazone (CCCP), chloramphenicol, tetracycline, cefalotin, mitomycin C, nalidixic acid and norfloxacin were purchased from Sigma (Madrid, Spain) and 2,4-dinitrophenol, boronic acid (phenylboronic acid) and paraquat were from Aldrich (Madrid, Spain). The remaining antimicrobial agents were purchased from their respective manufacturers.
The study was performed using two E. coli clinical isolates that were susceptible to lomefloxacin and ceftazidime, strains PS7 and PS11, which were isolated from urine samples from two inpatients at the Hospital Insular of Gran Canaria (Spain). E. coli AG112 (an OmpF-deficient strain) is a marR mutant derived from strain AG100. Both strains were donated by S. B. Levy (Tufts University, USA). 16 E. coli KL-16 and JF703 (OmpF deficient) were donated by M. K. B. Berlyn (E. coli Genetic Stock Centre, New Haven, USA) and were used as control strains for major outer membrane protein (OMP) profile analysis by SDS-PAGE.
Mutant selection
Spontaneous mutants with decreased susceptibility to the tested antimicrobial agents were selected on Mueller-Hinton agar plates containing lomefloxacin or ceftazidime at two or four times the MIC, as previously described. 17 Mutant selection was repeated on at least three separate occasions.
Susceptibility tests
MICs were determined following CLSI (formerly NCCLS) guidelines, 18 with and without the active efflux inhibitor CCCP (25 and 50 mM). This latter compound is an uncoupler that dissipates the transmembrane proton gradient. The proton gradient is the driving force of resistance nodulation division transporter systems such as AcrAB, AcrEF and AcrD. 11, 19 The dilution tests covered a full range (4096-0.015 mg/L) of 2-fold dilutions.
Susceptibility to mitomycin C, a DNA-damaging agent, was evaluated (using an agar diffusion method that has been previously described) because decreased susceptibility to mitomycin C has been associated with increased expression of the sdiA gene. 20 Likewise, 2,4-dinitrophenol susceptibility was assessed because the development of lon mutations in E. coli strains can increase 2,4-dinitrophenol susceptibility by 2-fold. In turn, lon protease mutations increase the cytosolic levels of MarA and influence acrB and tolC expression. 2 2,4-Dinitrophenol susceptibility was measured on LuriaBertani (LB) agar plates supplemented with 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1 or 1.2 mM 2,4-dinitrophenol after 24 h of incubation at 378C, as previously described.
21
A double-disc synergy test with clavulanic acid was used to identify possible ESBL production in parental strains and mutants. 22 The CLSI confirmatory test for ESBL production and a boronic acid disc test with or without clavulanic acid were performed (as previously described) by placing discs containing cefotaxime (30 mg) or ceftazidime (30 mg) alone, and discs containing cefotaxime (30 mg) or ceftazidime (30 mg) with or without boronic acid (400 mg) and/or clavulanic acid (10 mg) onto the agar. A ≥3 mm increase in the inhibition zone diameter of either the cefotaxime/boronic acid disc or the ceftazidime/boronic acid disc in the presence of clavulanic acid was considered indicative of an ESBL producer. 23 b-Lactamase hydrolytic activity b-Lactamase activity in sonicated extracts of parental strains and mutants was assayed using 100 mM benzylpenicillin and 100 mM cefaloridine in 0.05 M phosphate buffer (pH 7) at 258C. The activity was expressed as milliunits per mg of protein, where 1 U represents 1 mmol of substrate hydrolysed per min per mL of extract. 24 b-Lactamase activity values for each studied strain were derived from the mean determinations of at least three independent measures.
Transfer of b-lactam resistance
The possible transfer of resistance by conjugation was studied by a previously described method. 24 E. coli K12-C600 (donated by Dr F. Uruburu, Spanish Type Culture Collection, Valencia, Spain) was used as the recipient strain.
Analysis of OMPs and inner membrane proteins (IMPs)
OMPs were obtained from the pellet after sarkosyl treatment and IMPs were obtained from the supernatant fraction, as previously described. 7, 25 OMPs (20 mg of total protein) were separated on two different polyacrylamide gels: (i) the first was a 6 M urea/11% polyacrylamide gel to achieve better separation of the major OMPs, OmpC and OmpF; 25 and (ii) the second was a 12.5% polyacrylamide gel without urea, used to achieve better resolution of TolC, as previously described. 7 The wild-type strain AG100 was used as negative control for TolC overexpression. Both gels were stained with a Coomassie R-250 formulation purchased from Pierce, the Imperial Protein Stain Kit (Madrid, Spain).
Penicillin-binding proteins (PBPs) in supernatant fractions were labelled with Bocillin FL (a fluorescent penicillin) as previously described, 26 and separated in 12.5% polyacrylamide gels that were directly scanned with a Chemidoc TM System (Bio-Rad Laboratories, Madrid, Spain). The fluorescence intensity of each band was quantified by software (Quantity One 1-D analysis software; Bio-Rad Laboratories). The accepted standard deviation for these densitometric values was always ,5%.
Organic solvent tolerance
Tolerance to cyclohexane was measured by a liquid medium assay, as previously described. 27 At the early exponential phase of growth, the culture of each studied strain and the control AG100, already in Luria broth supplemented with 0.1% glucose and 10 mM MgSO 4 (LBGMg), was overlaid with a 10% volume of cyclohexane and incubated at 378C with shaking. Growth was monitored by measuring turbidity (optical density at 660 nm). 27 Cyclohexane tolerance values are reported as the mean determinations from at least three independent measures of optical density at 660 nm (OD 660 nm ) at 3 and 6 h after the addition of cyclohexane.
Increase in turbidity¼OD at 3 and 6 h after cyclohexane addition/OD immediately before cyclohexane addition.
The standard deviations for these values were all ,10%.
A total increase in turbidity of 2-to 3-fold in the first 3 -6 h after cyclohexane addition was considered significant following previous descriptions. 27 E. coli AG100 grown in the presence of salicylate (5 mM) was used as a positive control for tolC overexpression and as a standard for increased cyclohexane tolerance. Salicylate (5 mM) is a good inducer of marRAB regulon expression and, hence, tolC overexpression; 3, 8, 27 cyclohexane tolerance in E. coli is TolC dependent. 7 Cyclohexane assays address not only the possible overexpression of tolC, but also the necessary concomitant overexpression of efflux pumps exporting organic solvents, such as AcrAB and AcrEF. 7, 28 
RNA extraction
Overnight cultures of each strain were inoculated (1:100) in pre-warmed LB medium at 378C with shaking until the mixture reached an OD 600 nm of 0.4-0.5. Total RNA was isolated using TRI Reagent w from Ambion (Madrid, Spain) according to the manufacturer's instructions. 29 The concentration of total RNA was spectrophotometrically determined at 260 nm. Any genomic DNA was eliminated by the use of the DNA-free TM Kit from Ambion (Madrid, Spain) according to the manufacturer's instructions. The absence of DNA contamination in total RNA from each strain was assessed by subjecting RNA samples to 36 cycles of PCR amplification with glyceraldehyde 3-phosphate dehydrogenase (gapA) primers and analysis of final PCR products by electrophoresis through 1% agarose gels stained with ethidium bromide. At least three different RNA extracts were made from each strain.
Reverse transcription of total RNA and PCR of cDNA (RT-PCR)
Expression of the soxS, sdiA, marA, ftsI, tolC and acrB genes was studied by reverse transcription of total RNA and then PCR of the resulting cDNA (RT-PCR). The data obtained for gene targets were normalized against the reference gene gapA following previous descriptions. 29, 30 A 500 ng aliquot of total RNA was mixed with appropriate primers and the Superscript II RT-Platinum Taq reaction mixture from Invitrogen (Barcelona, Spain). Final reaction mixtures were first incubated at 508C for 30 min and then subjected to the following PCR program: 2 min at 948C, and then a number of cycles depending on the gene [gap (18 cycles), soxS (29 cycles), sdiA (26 cycles), marA (23 cycles), ftsI (24 cycles) and tolC and acrB (22 cycles)] for 1 min at 958C, 1 min at 558C [annealing temperature (Tm)] and 1 min at 728C, and a final extension for 5 min at 728C.
The primers utilized are listed in Table 1 . RT-PCR was done in triplicate for every RNA extract obtained from each strain and for the different analysed genes. The resulting PCR products (cDNA amplified by each primer pair tested) were separated in 12% polyacrylamide slab gels and detected using a DNA silver staining kit (Amersham Biosciences, Barcelona, Spain) as previously described. 29 The strain AG100 was induced with 5 mM salicylate or 0.2 mM paraquat and used as the control for marA and soxS gene overexpression, respectively. 3, 8, 31 The suitable number of cycles for studying the expression level of each gene was determined after several assays with different numbers of cycles, and a number of cycles was selected such that the putative overexpressed gene could be detected in silver-stained slab gels as a clean band, and the basal expression level of the same gene was a very thin band. A DNA ladder spanning 100-2072 bp (Ready-Load TM 100 bp DNA ladder from Invitrogen) was used to identify the overexpressed gene.
Densitometric analysis of the relative values of the studied genes in the clinical strains and mutants were compared with those in strain AG100. The levels of gene expression were quantified with the Quantity One 1-D analysis software (Bio-Rad Laboratories), using at least 10 different densitometric measurements of each band detected in the gels. The accepted standard deviation for these densitometric values was always ,5%.
Changes ≥1.3-fold in the gene expression levels were considered significant, as previously described. 32 PCR amplification and DNA sequencing of the acrR gene and the quinolone resistance-determining region (QRDR) of the gyrA, gyrB, parC and parE genes Mutations in the acrR gene and the QRDR of the gyrA, gyrB, parC and parE genes of the four studied E. coli strains were identified by DNA sequencing of their PCR products using the method and primers previously described. 10, 33, 34 Likewise, two additional oligonucleotide primer pairs,
′ (U00096, Tm, 508C), were used to amplify overlapping products of ≤411 bp of the acrR sequence.
Results
Identification of MDR phenotypes
Spontaneous mutants that were less susceptible to lomefloxacin or ceftazidime were selected from the parental strains PS7 and PS11. Selection frequencies were 10 29 when mutants were selected with 4-fold the MIC of lomefloxacin or ceftazidime and were 10 28 when selected with 2-fold the MIC of lomefloxacin or ceftazidime. Based on the profile of susceptibility to the tested antimicrobial agents, only two different clones were detected among the selected mutants (LomE7 and CazE11 strains), and these were further characterized in this work. LomE7 and CazE11 were selected with 4-fold the MIC of lomefloxacin and ceftazidime, respectively. Both mutants showed decreased susceptibility to multiple antimicrobial agents including quinolones, chloramphenicol and b-lactams (Table 2) . Otherwise, no stable mutants were selected from the AG100 strain.
The two different concentrations of CCCP enhanced the susceptibility of the two mutant strains equally, since the effect of CCCP at both 25 and 50 mM increased the susceptibility of the mutant strains to the tested antimicrobial agents 2-to 16-fold.
LomE7 and CazE11 increased the susceptibility to 2,4-dinitrophenol. Growth was inhibited by concentrations of ≥0.65 and 0.75 mM (2,4-dinitrophenol MICs of 0.65 and 0.75 mM), respectively, whereas the parental strains AG100 and AG112 were only inhibited by 2,4-dinitrophenol concentrations ≥1.2 mM (2,4-dinitrophenol MIC of 1.2 mM).
SDS-PAGE and Imperial Protein Staining analysis of OMPs revealed reduced OmpF levels with a simultaneous increase in OmpC expression in both the LomE7 and CazE11 strains (Figure 1a ). In addition, Imperial Protein Staining of 12.5% SDS-polyacrylamide gels (without urea) revealed increased expression of an OMP of 53 kDa in both mutants compared with their parental strains and AG100, in which the band was not evidenced. The band showed the same mobility profile by SDS-PAGE without urea that was identified as TolC by Aono et al. 7 using the same method. Likewise, an OMP of 25 kDa was increased in LomE7 (Figure 1b) .
Organic solvent tolerance in mutants
The analysis of cyclohexane tolerance showed that while the turbidity of parental strain and AG100 cultures stopped increasing immediately after the addition of cyclohexane, turbidity in LomE7 and CazE11 cultures continued to rise. There was an increase in turbidity of 2.8-to 3.1-fold in the two mutants in the first 3-6 h after cyclohexane addition (Figure 2 ). In the presence of 5 mM salicylate, the increase in cyclohexane tolerance of both mutants was ,10%, as is expected for strains in which tolC is overexpressed. In contrast, the parental strains and AG100 doubled their level of cyclohexane tolerance when grown with salicylate.
Reduced susceptibility of the mutants to mitomycin C Obvious differences in mitomycin C susceptibility between the mutants and their parental strains were observed. The parental strains showed 28 mm (PS7 strain) and 25 mm (PS11 strain) inhibition zones with 15 mg of mitomycin C, while both mutants showed inhibition zones of 17 mm. CCCP did not modify the mitomycin C susceptibility of either of the two mutants.
Increased tolC and acrB expression concomitant with marA, sdiA and soxS overexpression
The sdiA, marA, tolC and acrB genes were overexpressed in both studied mutants with respect to their parental strains ( Table 3 ). The transcript level of soxS only increased in the CazE11 mutant compared with its parental strain (PS11), reaching a slightly higher level than that found in the wild-type strain (AG100) following induction with 0.2 mM paraquat (Table 3) . Also, elevated expression of ftsI was detected in LomE7 (16.22-fold that of AG100), although the ftsI transcript level was already higher in its parental strain PS7 than in AG100 (14.44-fold) or in the remaining analysed strains (Table 3) .
Analysis of mutations in QRDRs
The analysis of mutations in the QRDR of the gyrA gene revealed the presence of a single mutation at codon 83 in PS7 and LomE7, which consisted of a C T transversion in the codon TCG, sdiA and marA overexpression in E. coli mutants resulting in a Ser83 Leu substitution in the GyrA subunit. No mutations were found in the QRDR of the gyrA gene in PS11 and CazE11. Likewise, no mutations other than silent nucleotide substitutions were found in the amplified fragments of the gyrB, parC and parE genes in the four studied strains.
Genetic analysis of acrR
The analysis of the acrR gene revealed that the four studied strains carried silent mutations. PS7, LomE7, PS11 and CazE11 showed three silent mutations in the following DNA positions: 485089 GGC GGT; 485203 CTA CTC; and 485277 GAA GAG. Likewise, PS11 and CazE11 also had two additional silent mutations in 485569 GTT GTC and 485614 AAT AAC. Nevertheless, changes in the amino acid chain were only found in LomE7. There was a 2 nt duplication between codons 62 and 63 (ATC TGG ATC TCT) compared with the sequence of its parental strain PS7 and the acrR gene sequence according to GenBank sequence accession no. U00096. The duplication resulted in the change of Trp63 Ser and generated a frameshift, which removed residues of the N-terminal DNA-binding and C-terminal domains of AcrR. 35 No other mutations were found in the studied strains.
b-Lactamase characterization in the parental strains and the mutants
Despite the mutants' increased resistance to cephalosporins with respect to their parental strains, the hydrolytic activity of LomE7 crude extract against benzylpenicillin or cefaloridine did not increase more than 1.1%, while the hydrolytic activity against cefaloridine of the CazE11 crude extract increased 1.65% with respect to its parental strain PS11 (Table 4) .
A double-disc synergy test between each tested cephalosporin and clavulanic acid detected synergy in neither the parental strains nor the mutants. Likewise, the increases in the inhibition zone diameters of cefotaxime (30 mg) and ceftazidime (30 mg) in the presence of clavulanic acid were all ,5 mm in the parental strains and the mutants. In turn, a test with boronic acid detected ESBL production in neither the parental strains nor the mutants, since the increases in the inhibition zone diameters of either the cefotaxime/boronic acid or ceftazidime/ boronic acid discs in the presence of clavulanic acid were all ,3 mm.
Transconjugation experiments failed to transfer ceftazidime resistance from LomE7 or CazE11 to E. coli K12-C600.
Increased expression of PBP3 (ftsI) in the mutant selected with lomefloxacin and its parental strain Labelling of IMPs with Bocillin FL revealed a fluorescent band at 60 kDa in PS7 and LomE7 with a significantly increased intensity of 9.18-and 14.53-fold, respectively, compared with AG100. The band in the mutants was also 1.9-to 3.3-fold more intense than the same band in the other studied strains. This band showed a profile migration similar to that previously identified for PBP3 in E. coli. The intensity increases in the 60 kDa band in PS7 and LomE7 were higher than the previously described PBP3 overproduction in E. coli associated with increased resistance to PBP3-targeted antibiotics (7-fold higher than the amount of native PBP3 present in the wild-type strain). 36 Other changes in the PBP profiles of the mutants with respect to their parental strains were not detected (Figure 3) .
Discussion
This study assessed the potential contribution of the stress response transcriptional regulator sdiA to low-level MDR phenotypes in two mutants selected with lomefloxacin and ceftazidime in vitro. The concurrent overexpression of sdiA with other stress response regulators was also analysed.
The two mutants, LomE7 and CazE11, exhibited MDR phenotypes consisting of decreased susceptibility to quinolones, chloramphenicol, b-lactams and mitomycin C, but unchanged resistance to tetracycline. Nevertheless, the increase in the quinolone MICs was unequal between LomE7 (16-to 64-fold) and CazE11 (2-to 16-fold). This finding suggested the presence of mutations in the QRDR of the genes encoding DNA gyrase and topoisomerase IV in the mutant selected in vitro with a fluoroquinolone, LomE7, since the increases in quinolone resistance mediated by efflux pumps have been previously constrained to an 10-fold maximum, 19 as in the case of CazE11. The presence of CCCP resulted in increased susceptibility of the two mutants to chloramphenicol, tetracycline, norfloxacin and all tested b-lactams, indicating that enhanced active efflux contributes to MDR phenotypes in both mutants. In turn, the analysis of mutations in QRDRs demonstrated the presence of a single gyrA mutation, Ser83 Leu in LomE7, which already occurred in its parental strain PS7. Therefore, the gyrA mutation combined with increased active efflux in LomE7 may explain the 16-to 64-fold increase in the fluoroquinolone MICs, as has been previously described in other E. coli strains. 16, 34 RND (resistance-nodulation -division) transporters (including AcrB and AcrF) need the outer membrane channel TolC for effective transport of b-lactams and other agents (such as cyclohexane) from the periplasm into the external medium. 7, 28, 37 Analysis of OMP and RNA confirmed TolC overexpression, which was initially suspected because of the results on increased cyclohexane tolerance and weak salicylate induction effect on cyclohexane tolerance in both studied mutants in comparison with their parental strains.
In addition to TolC, AcrB overexpression was also demonstrated in LomE7 and CazE11. The overexpression of marA, soxS or sdiA can increase the transcript levels of both acrB and tolC. 3, 7, 13 In the case of the two studied mutants, the increase in marA transcription identified by RT-PCR (1.99-and 4.46-fold with respect to the control strain AG100) resembled the previously described effect of 5 mM salicylate (a well-known inducer of MarA) on AG100. 38 The increase was probably due to a mutation in marR in both mutants, as has been previously described in AG112 (mutant marR). 39 In fact, an E. coli mutant marR was in vivo selected during therapy with ciprofloxacin. 39 The increased transcript level of soxS in CazE11 (2.56-fold greater than in AG100) resembled the effect of 0.2 mM paraquat on AG100 and contributed to the elevated acrB transcript level in this mutant. Nevertheless, mutations in the acrR repressor gene are more likely to be involved in acrB derepression than mutations that lead to marA or soxS overexpression. 9 Therefore, possible mutations in the acrR gene as contributors to overexpression of acrB were studied by DNA amplification and sequencing. Only LomE7 carried a mutation in acrR that modified the AcrR protein sequence, a 2 bp duplication that resulted in a frameshift starting at position Trp63 and transcription termination (TAA) three codons later, leading to a truncated protein. This result may explain why the acrB transcript level was 1.6-fold higher in LomE7 than in CazE11, despite the elevated transcript levels of marA, sdiA and soxS in the mutant selected with ceftazidime, since mutations in the repressor AcrR have been associated with higher transcript levels of acrB than marA or soxS overexpression. 9 Likewise, a nucleotide duplication in acrR has been previously described in an E. coli isolate highly resistant to ciprofloxacin and ceftazidime. 40 In turn, MarA overexpression (in addition to SoxS in the case of CazE11) was responsible for the loss of OmpF in both mutants. This effect modifies the cell wall permeability to b-lactams and other antimicrobials, such as norfloxacin, which preferentially pass through OmpF. 24 Intracellular levels of MarA and SoxS can also be amplified by a reduction in the level of Lon protease, which is a homotetramer of 450 kDa that degrades a number of cellular proteins (including MarA and SoxS). It has been previously demonstrated that lon mutations increase the half-life of SoxS and MarA. 2, 41 The two characterized mutants, LomE7 and CazE11, were 1.85-and 1.6-fold more susceptible to 2,4-dinitrophenol than either their parental strains or AG100, similar to a previous description in a lon mutant of strain AG100. 21 This finding suggests a lower Lon protease activity in both mutants, which could promote an additional increase in MarA in the cytoplasm by a low degradation rate of this protein, and not solely due to increased marA transcription.
The transcriptional regulator SdiA has a global impact on several cellular functions in response to stress conditions, 13 and it influences the expression of at least 137 genes. 42 In the present study, the transcript level of sdiA increased not only in LomE7 (5.04-and 11.08-fold in the mutant selected with a fluoroquinolone with respect to PS7 and the wild-type strain, respectively), but also in CazE11 (6.3-and 15.27-fold in the mutant selected with a cephalosporin with respect to PS11 and AG100, respectively) in the absence of the selective agents lomefloxacin and ceftazidime. These latter results suggest a possible mutation in a still unknown regulator of sdiA. In turn, the increased resistance to mitomycin C not modified by CCCP, which was observed in the two mutants, was consistent with the increased transcript levels of sdiA. In fact, it has been previously suggested that the amplification of sdiA could confer mitomycin C resistance through an increased capacity for chromosomal replication and repair upon sdiA overexpression. 13, 20 The increased transcript levels of sdiA in the two mutants were equivalent or slightly higher than the previously described sdiA transcript levels. Following this previous description, an increase of at least 5-fold in the sdiA transcription level was necessary to lead to changes in the expression of genes related to the quorum-sensing response, 43 while in the present study the increase in the parental strains was 2.2-to 2.43-fold with respect to AG100.
Up to now, the correlation between sdiA amplification and quinolones has been attributed to the resemblance of quinolones to some cellular communication molecules. 12 Likewise, homoserine lactones and indole can activate sdiA. 44 In the present study, selection with ceftazidime seemed to trigger sdiA amplification as well. The E. coli LuxR homologue SdiA is a positive regulator of the AcrAB-TolC pump, as well as of the acrD and acrEF RND efflux systems. 13, 19 Overexpression of the AcrD efflux pump together with AcrAB and/or AcrEF could possibly multiply the level of resistance in LomE7 and CazE11 mutants, as previously described. 45 AcrD overproduction has been associated with an 8-fold increased resistance to aztreonam. 37 Also, AcrB or AcrF overexpression is associated with increased cefotaxime and ceftazidime MICs. 37 LomE7 and CazE11 were 32-to 128-fold more resistant to ceftazidime and 4-to 32-fold more resistant to cefpirome than their parental strains. However, this latter finding cannot be completely explained by either OmpF decrement or active efflux, as resistance to ceftazidime and cefpirome in the two mutants did not totally revert after CCCP addition. Moreover, the MICs of ceftazidime and aztreonam should increase by ,2-fold following a loss of OmpF, as previously described. 46 Similarly, the non-transferable b-lactam resistance phenotype could not be explained by b-lactamase production. One possibility is that AmpC overproduction could be responsible for the reduced susceptibility of the mutants to cefoxitin and third-generation cephalosporins, particularly ceftazidime, in the absence of ESBL production, as previously described. 22 However, this possibility was ruled out after determination of the b-lactamase hydrolytic activity in LomE7 and CazE11. Both mutants and their parental strains showed low levels of b-lactamase hydrolytic activity in comparison with previous descriptions of E. coli and other enterobacterial strains that overproduce AmpC b-lactamases. 46, 47 In fact, the imipenem MIC did not show any variation between the two mutants and their parental strains, despite OmpF deficiencies in both LomE7 and CazE11. It should be noted that decreased susceptibility to imipenem in E. coli can arise from high-level expression of class C b-lactamase combined with an OMP deficiency, but not solely from porin deficiency, despite the high diffusion rate of imipenem through F and C channels. 48, 49 Likewise, E. coli carries a chromosomal gene for AmpC b-lactamase that is normally expressed in negligible amounts. 23 Therefore, we evaluated the expression of a possible fourth contributor to b-lactam resistance, PBP. Ceftazidime, cefpirome and aztreonam preferentially inhibit PBP3 (FtsI), 50, 51 which is a cytoplasmic membrane protein that functions as a DD-transpeptidase in the formation of the septum at the murein sacculus and is a principal lethal target for b-lactam antibiotics. 52 It has an apparent molecular weight of 60 kDa on 12.5% SDS -PAGE. 52 The study of IMPs on polyacrylamide gels with Bocillin FL and the analysis of ftsI transcript levels demonstrated a higher level of PBP3 expression in LomE7 (16.22-fold) and in its parental strain PS7 (14.44-fold) than in the wild-type AG100 or the remaining studied strains. Therefore, increased production of PBP3, which already occurred in the parental strain PS7, combined with increased active efflux and decreased permeability due to OmpF loss, may explain the increased ceftazidime, cefpirome and aztreonam MICs in LomE7. In fact, ftsI overproduction alone can increase ceftazidime MICs by 4-to 8-fold and aztreonam MICs by 2-fold. 36 In conclusion, sdiA and marA up-regulation was a common strategy developed by bacterial cells to survive concentrations of lomefloxacin and ceftazidime that are higher than their respective parental strains are capable of surviving. There may be a close relationship between these bacterial stress response regulators that is not yet fully elucidated. Likewise, a possible role for lon mutations favouring development of the MDR phenotype must not be overlooked. In fact, lon mutations may increase genome instability and favour spontaneous large tandem duplications. 2 Further analysis is needed to deepen our knowledge of the molecular relationships among these regulator proteins.
